| Brian Richard Stephany, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Brian Richard Stephany |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 25 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346338860 | NPI | - | NPPES |
| 2472828 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 4301507625 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Lakeland Hospital, St Joseph | St joseph, MI | Hospital |
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Cleveland Clinic | Cleveland, OH | Hospital |
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
The most difficult challenge in finding substance abuse treatment for a loved one is how to know which programs have a proven track record. That is just one of the topics being discussed today at the conference "Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities." Held at the Duke Energy Center in Cincinnati, the conference is hosted by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. It is part of NIDA's Blending Initiative, in which teams of experts create clinical tools based on the latest treatment research.
A latest study suggests that children with severe milk allergies may be able to rapidly overcome their sensitivities with the help of a biologic drug that helps to quiet an overly aggressive immune response. This is a small study still waiting to be proved in larger populations say researchers.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
› Verified 4 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003848144 PECOS PAC ID: 3779496856 Enrollment ID: O20031121000236 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
The most difficult challenge in finding substance abuse treatment for a loved one is how to know which programs have a proven track record. That is just one of the topics being discussed today at the conference "Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities." Held at the Duke Energy Center in Cincinnati, the conference is hosted by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. It is part of NIDA's Blending Initiative, in which teams of experts create clinical tools based on the latest treatment research.
A latest study suggests that children with severe milk allergies may be able to rapidly overcome their sensitivities with the help of a biologic drug that helps to quiet an overly aggressive immune response. This is a small study still waiting to be proved in larger populations say researchers.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Richard Stephany, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Brian Richard Stephany, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.
The most difficult challenge in finding substance abuse treatment for a loved one is how to know which programs have a proven track record. That is just one of the topics being discussed today at the conference "Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities." Held at the Duke Energy Center in Cincinnati, the conference is hosted by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. It is part of NIDA's Blending Initiative, in which teams of experts create clinical tools based on the latest treatment research.
A latest study suggests that children with severe milk allergies may be able to rapidly overcome their sensitivities with the help of a biologic drug that helps to quiet an overly aggressive immune response. This is a small study still waiting to be proved in larger populations say researchers.
A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.
› Verified 4 days ago
Nabil Alkhoury Fallouh, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 East Medical Center Dr, 3rd Floor Taubman Ctr Recp B, Ann Arbor, MI 48109 Phone: 734-936-5582 | |
Sameer Dev Saini, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. David Alexander Stewart, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, 12th Floor C.s. Mott Children's Hospital Room 525, Ann Arbor, MI 48109 Phone: 734-763-5302 Fax: 734-647-5624 | |
Dr. Aiman M Mahmood, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Med Inn C728, Ann Arbor, MI 48109 Phone: 734-998-0891 | |
Anastasia Irene Wasylyshyn, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Katherine Saber Salisbury, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4260 Plymouth Rd, Ann Arbor, MI 48109 Phone: 734-764-6831 | |
Anne Lewis Carlton, Nephrology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-647-5900 |